Lanton

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lanton

Lanton: Quick Facts

Property Description
Active ingredient Lansoprazole (INN)
Form Delayed-Release Capsule, Oral Suspension
Pharmacological class Proton Pump Inhibitor (PPI)
Common use Reduction of gastric acid
Origin Synthetic compound

What Type of Drug is Lanton?

The medicine known as Lanton contains the active ingredient Lansoprazole, which is categorized as a Proton Pump Inhibitor (PPI), a designation placing it within a major class of medications clinically recognized for reducing gastric acid secretion. Lansoprazole is a synthetic compound chemically defined as a substituted benzimidazole derivative. PPIs offer a distinct advantage over older treatments, such as H₂-receptor antagonists, by targeting the terminal stage of acid production, thereby ensuring a more complete and predictable level of acid suppression.

Lansoprazole: The Active Ingredient and Form

Lansoprazole (INN) is a single-ingredient product administered via the oral route, typically supplied as specialized delayed-release capsules and sometimes as an oral suspension. The compound's high sensitivity to acid necessitates this specific engineering. This medication is recognized as a potent inhibitor of gastric acidity used widely in the therapy of acid-related disorders. For the patient, this confirms that Lansoprazole is a powerful agent specifically designed to tackle issues caused by too much stomach acid. The use of delayed-release forms is crucial because it ensures the compound remains intact when passing through the stomach, only releasing its active components for absorption in the small intestine.

What is the General Purpose of Lanton?

The general purpose of Lansoprazole is to provide consistent, powerful control over the level of acid in the stomach. This function is achieved by directly and irreversibly blocking the body's primary mechanism for secreting gastric acid. By dramatically reducing the overall acidity, Lansoprazole is commonly used to support the natural healing of irritated or damaged tissues associated with various acid-related conditions in the gastrointestinal tract, thereby achieving its therapeutic objective.

What side effects are possible with Lanton?

Possible Side Effects and Safety Information

The safety profile for Lanton (Lansoprazole) is based on classifications from official regulatory documents and includes adverse reactions grouped by frequency and the body system affected. These classifications structure the understanding of possible effects.

Frequency-Classified Adverse Reactions

The most Common adverse reactions documented in official sources often involve the digestive system and the nervous system, including effects such as headache, diarrhea, abdominal pain, nausea, and constipation.

Reactions categorized as Uncommon include instances of arthralgia (joint pain) and myalgia (muscle pain). More serious reactions are often classified as Rare or of Not Known frequency, having been identified primarily through post-marketing surveillance.

Serious Adverse Reactions and Duration-Related Risks

The regulatory label documents specific, serious, though often rare, adverse reactions, including the risk of Acute Tubulointerstitial Nephritis (TIN), which can occur at any point during treatment. There is also an increased risk of severe infections, such as Clostridium difficile-Associated Diarrhea (CDAD), associated with therapy.

Specific safety concerns are linked to the duration of exposure:

  • Long-Term Use (typically one year or more): Associated with an increased risk of developing bone fractures of the hip, wrist, or spine, and potential hypomagnesemia (low magnesium levels).
  • Prolonged Use: Linked to the development of Fundic Gland Polyps and Vitamin B12 deficiency.

Safety Constraints and Special Populations

The safety documentation notes that the symptomatic response to Lanton therapy does not exclude the presence of an underlying gastric malignancy. Furthermore, the medication may interfere with diagnostic testing for neuroendocrine tumors by raising certain markers. Safety constraints are noted for specific populations; for instance, the daily dose may need to be restricted in individuals with severe hepatic impairment, while generally older adults do not require a dosage adjustment.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation states that an overdose of Lanton is associated with low acute toxicity, meaning it does not generally result in unique, life-threatening symptom clusters. Regulatory reports, including documented cases of high-dose ingestion (e.g., 600 mg), often show minimal or no severe adverse effects. However, exposure to high doses may lead to an exaggeration of known, common adverse reactions, such as headache, nausea, vomiting, or other gastrointestinal upset.

Regardless of the clinical presentation, any suspected or confirmed overdose mandates immediate medical attention. Regulatory guidelines explicitly require patients or caregivers to contact a Poison Control Center right away or seek emergency medical care for guidance.

Management of a Lanton overdose is strictly symptomatic and supportive, as no specific antidote is known to reverse the drug’s effects. Due to this absence, official protocols may include procedural interventions such as gastric emptying and the administration of charcoal to limit absorption. The active ingredient is highly protein-bound, meaning hemodialysis is not expected to be an effective method for removal. The official labeling does not contain specific overdose statements regarding severity or management for special populations.

Therapeutic Uses of Lanton

Quick Facts

  • Active Duodenal Ulcer: Indicated for short-term care to support healing.
  • Gastric Ulcer: Appropriate for the management of active benign gastric ulcers, and for healing ulcers associated with NSAID use.
  • GERD (Gastroesophageal Reflux Disease): Used for the short-term treatment of symptomatic GERD and to assist with the healing of erosive esophagitis (EE).
  • Risk Reduction: Appropriate to help reduce the risk of recurrence of duodenal ulcers following H. pylori eradication, and for reducing the risk of NSAID-associated gastric ulcers in at-risk patients.
  • Hypersecretory Conditions: Appropriate for the long-term management of conditions involving excessive stomach acid production, such as Zollinger-Ellison syndrome.

What Lanton Treats: Main Uses and Benefits

Lanton is a prescription medication utilized in therapeutic regimens focused on reducing the presence of stomach acid. It is intended to provide care for a range of conditions related to elevated stomach acid levels, which can affect the esophagus, stomach, and duodenum.

The medication is employed for the short-term treatment of symptomatic gastroesophageal reflux disease (GERD) to alleviate associated discomfort, and for the short-term management of erosive esophagitis (EE) to support the healing process of acid-related damage to the esophagus lining. Lanton is also an indicated component for the short-term treatment of active duodenal ulcers and active benign gastric ulcers.

For patients taking Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Lanton is appropriate to reduce the risk of developing NSAID-associated gastric ulcers and to facilitate the healing of such ulcers when they occur. Furthermore, when used in combination with appropriate antibiotics, Lanton is included in a regimen to eradicate H. pylori bacteria, which helps to reduce the risk of duodenal ulcer recurrence. It is also utilized for the long-term care of pathological hypersecretory conditions, including Zollinger-Ellison syndrome.

Eligibility and Restrictions for Use

Who Can and Cannot Use Lanton?

The population eligibility for Lanton (Lansoprazole) is strictly defined by government regulatory documents, outlining who may use the medicine and under what conditions.

Lanton is contraindicated in patients with a known severe hypersensitivity to the drug or any component of the formulation. Absolute exclusion also applies to individuals receiving rilpivirine-containing products or those with rare hereditary metabolic disorders, such as fructose intolerance, due to the drug's excipients.

Category Eligibility Status Key Restriction or Condition
Age Groups Approved / Restricted Approved for adults and children mathbf1 year of age and older for specific conditions. Use is not recommended for infants less than 1 year old due to unestablished efficacy and safety concerns.
Organ Function Conditional Patients with moderate or severe hepatic (liver) impairment require special caution and must be supervised, often necessitating a dose reduction. No dose adjustment is required for renal (kidney) impairment.
Reproductive Status Not Recommended Use during pregnancy or breastfeeding is not recommended due to a lack of adequate human safety data, requiring a decision to discontinue the drug or nursing.

Additionally, eligibility is conditional for gastric ulcer patients: the presence of a malignant tumor must be excluded prior to starting treatment. Furthermore, use for NSAID ulcer prevention is restricted to high-risk patients.

What should I know about interactions with other medicines?

Lanton Interactions with other medicines and products

The interaction profile for Lanton is structured around regulatory constraints derived from its influence on gastric pH and its role in metabolic pathways.

Category Official Regulatory Information
Medicinal product categories with documented interactions Antivirals (HIV protease inhibitors), antifungal agents, anti-coagulants, immunosuppressants, antiplatelet agents, cardiac glycosides, xanthine derivatives.
Specific interacting medicines (if explicitly listed) Atazanavir, Nelfinavir, Ketoconazole, Itraconazole, Digoxin, Methotrexate, Tacrolimus, Warfarin, Theophylline, Sucralfate.
Timing-based interaction rules (if applicable) Sucralfate must be administered at least 30 minutes after Lansoprazole.
Interaction-related restrictions Co-administration is formally prohibited with Atazanavir and Nelfinavir.

Official interaction statements:

Co-administration is formally prohibited with Atazanavir and Nelfinavir because the resulting reduction in stomach acid substantially decreases their systemic exposure. Lansoprazole is documented as an inhibitor of the CYP2C19 enzyme, and it is also metabolized by CYP2C19 and CYP3A4.

Exposure of other medicines is altered due to pH-dependent absorption changes. Absorption of medicines requiring an acidic environment, such as Ketoconazole and Iron Salts, is reduced. Conversely, plasma concentrations of Digoxin may be increased. Monitoring is required for co-administration with Warfarin, Tacrolimus, and Methotrexate, where an increase in their systemic exposure is documented. Administration with Food is officially documented to reduce Lansoprazole's bioavailability by 50% to 70%, and the herbal product St. John's Wort may decrease its effectiveness. In patients with Hepatic Impairment, slower clearance may affect the severity of certain interactions.

Mechanism of Action

How Lanton Works: Mechanism of Action

Lanton operates as a prodrug, requiring activation within the highly acidic environment of the secretory canaliculus in the gastric parietal cells. Once protonated, the active sulfonamide metabolite binds covalently and irreversibly to specific cysteine residues on the H^+/ K^+-ATPase enzyme, commonly known as the proton pump.

This targeted molecular interaction permanently inactivates the enzyme, blocking the final stage of acid secretion (the exchange of intracellular H^+ for luminal K^+). The resulting pathway interference leads to a prolonged inhibition of hydrogen ion release into the stomach lumen. The physiological consequence of this mechanism is a significant and sustained elevation of the gastric pH (decreased acidity), which limits the pH-dependent activation of digestive enzymes like pepsin, thereby modulating the chemical environment of the upper gastrointestinal system.

Dosage and Administration Information

Administration and Dosing of Lanton

The administration of Lanton, which contains lansoprazole, is based on oral intake of its approved delayed-release forms, including capsules, orally disintegrating tablets (ODTs), and oral suspension. To ensure the integrity of the enteric coating required for proper absorption, all forms must not be crushed or chewed.

Dosing Patterns and Frequency

Lanton should be taken before a meal, typically once daily in the morning, which is critical for its intended action. The standard dose for initial treatment of erosive esophagitis is 30 mg once daily, while 15 mg once daily is commonly used for long-term maintenance. If the total daily dosage for hypersecretory conditions exceeds 120 mg, the dose is typically administered in divided doses (e.g., twice daily).

Special Handling and Missed Doses

For patients who cannot swallow the capsule whole, the contents (granules) may be opened and sprinkled onto soft foods or mixed with specific fruit juices for immediate consumption. For nasogastric tube administration, the intact granules must be mixed with 40 mL of apple juice only. A reduction to 15 mg once daily is specified for patients with severe hepatic impairment.

If a dose is missed, it should be taken as soon as remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and a double dose must not be taken to compensate. These instructions define the standardized, procedural steps for using the medication.

Recent Clinical Evidence

Research Evidence / Overview of Studies

A. Research Focus on Compound Activity

Mechanistic research focused on the compound's effect on a specific enzyme involved in the inflammatory pathway. Investigators explored whether changes in discomfort and recovery time were observed in research models.


B. Pre-Clinical Findings

1. In Vitro and Animal Studies

Early research examined the concentration-dependent activity of the compound in cell cultures. Animal models of induced inflammation were used to explore tolerability and preliminary symptom response.

2. Pharmacokinetics

Studies assessed how the compound is absorbed, distributed, metabolized, and excreted. The half-life of the compound was reported to be approximately 8 hours.


C. Clinical Trial Results

1. Efficacy Data

Studies evaluated whether daily function and quality of life were affected over six months. Long-term differences compared to placebo were examined in a randomized controlled trial (RCT). Research has explored whether using this drug with Drug Y is associated with changes in the overall outcome.

A small study reported that a decrease in primary symptoms was measured at the 48-hour assessment point. A Phase 3 trial reported an ongoing decrease in symptoms over the study period.

2. Safety and Tolerability

The compound has been studied for short-term use in adults. Study populations did not include individuals with severe liver impairment.

Common adverse events reported in the clinical trials included mild nausea (12% of participants) and headache (9% of participants). Serious adverse events were infrequently reported.

Key Studies & References

  1. Integrated Analysis of the Safety Experience in Adults with the Bivalent Respiratory Syncytial Virus Prefusion F Vaccine (Used for general safety data structure, common AEs, and SAEs percentages)

Frequently Asked Questions (FAQ)

Common questions about Lanton (FAQ)


Q: What is the main thing Lanton is used for?

A: Lanton is formally indicated in regulatory documents for the treatment and maintenance of conditions related to excessive stomach acid. These include healing damage caused by reflux (erosive esophagitis), and symptomatic gastroesophageal reflux disease (GERD), as well as duodenal ulcers.


Q: Why do doctors prescribe Lanton?

A: Doctors prescribe Lanton because official documentation confirms its ability to reduce the production of stomach acid. This makes it a standard treatment for healing ulcers, reducing the symptoms of GERD, and treating related hypersecretory conditions.


Q: Is Lanton a type of antibiotic?

A: Lanton is not an antibiotic; it is officially classified as a Proton Pump Inhibitor (PPI). It may be used alongside a course of antibiotics when treating H. pylori infections, which are often the underlying cause of ulcers.


Q: Is Lanton a controlled substance?

A: Official regulatory documents state that Lanton is not classified as a controlled substance by government agencies.


Q: Does Lanton treat the cause of the problem or just the symptoms?

A: Lanton works by blocking the final stage of acid production in the stomach, which relieves symptoms such as heartburn. By reducing acid, the medicine helps the body's natural healing process to repair acid-related damage, such as ulcers and erosions.


Q: What is the drug class of Lanton?

A: Lanton is classified in official drug regulatory documents as a Proton Pump Inhibitor (PPI). This class of medication is designed to specifically target and reduce acid production in the stomach.


Q: How long does it take to start feeling the effects of Lanton?

A: According to official product information, Lanton is not intended to provide immediate relief for sudden heartburn symptoms. It may take 1 to 4 days of continued use before the medication's full acid-blocking effect is achieved.


Q: How long do the effects of Lanton last after a single use?

A: The mechanism of action for Lanton involves it binding irreversibly to the acid-producing pumps in the stomach lining. This action results in a prolonged reduction of acid secretion, which is why Lanton is usually taken only once daily.


Q: Can Lanton be used long-term?

A: While most treatment regimens are short-term, use beyond a few months is sometimes necessary for certain severe or chronic conditions. Official safety communications note that prolonged use has been associated with potential risks such as bone fractures and low levels of magnesium or Vitamin B12.


Q: What happens if Lanton is stopped suddenly?

A: Authoritative medical reviews have noted the observation of a temporary increase in acid production, sometimes referred to as 'rebound,' when Lanton is discontinued abruptly after a period of prolonged use.


Q: Is it okay to take Lanton every day?

A: Regulatory documents state that Lanton is prescribed for both short-term treatment and longer-term daily maintenance of certain healed conditions. Long-term daily use is described in official information, typically at the lowest effective dose necessary for the specific indication.


Q: Does Lanton cause weight gain?

A: Weight gain is not commonly listed among the frequently reported adverse events in the official regulatory documentation.


Q: Is feeling dizzy a common side effect of Lanton?

A: Official adverse event data lists dizziness as one of the reported side effects associated with Lanton.


Q: Can Lanton affect sleep?

A: Official regulatory documents list side effects such as drowsiness, fatigue, anxiety, and nervousness. While not a direct sleep medication, these reported effects could potentially impact sleep patterns.


Q: Are there any serious side effects associated with Lanton?

A: Serious adverse events documented in official sources include possible increased risks of bone fractures (hip, wrist, spine), low blood magnesium levels, and Clostridium difficile-associated diarrhea (a specific type of intestinal infection).


Q: What are the most common side effects listed for Lanton?

A: According to official regulatory documentation, the most frequently reported side effects include headache, diarrhea, nausea, and abdominal pain.


Q: Does Lanton interact with alcohol?

A: Official patient information from some regulatory bodies notes that avoiding excessive alcohol intake is suggested if individuals experience certain side effects, like headaches, while taking Lanton. A general prohibition against moderate alcohol use is typically not listed in the main interaction documents.


Q: Can Lanton be taken with supplements like vitamins or herbal remedies?

A: Official regulatory warnings note that long-term use of Lanton may interfere with the body’s absorption of certain micronutrients, including Vitamin B12 and Magnesium. The official label does not provide specific advice on every supplement, but absorption is a documented factor.


Q: Is it safe to drive after taking Lanton?

A: Official regulatory guidance states that if Lanton causes symptoms such as dizziness or feeling tired, individuals should exercise caution and avoid activities requiring high attention, such as driving or operating heavy machinery.


Q: Can people with kidney problems use Lanton?

A: Regulatory documents note that Acute Interstitial Nephritis, a type of kidney inflammation, is a documented serious adverse event observed with PPIs. While Lanton is generally not dose-adjusted for decreased kidney function, official warnings confirm that kidney status is a relevant safety consideration.


Q: Is Lanton approved for use in children?

A: Lanton is formally approved by regulatory bodies for use in pediatric patients beginning at 1 year of age. This approval is for the short-term treatment of GERD and erosive esophagitis, with specific dosing recommendations for this age group.


Q: Can older adults (seniors) take Lanton?

A: Older adults are generally eligible to use Lanton. Regulatory safety communications highlight that individuals aged 50 and older are included in the demographic studied regarding the increased risk of bone fractures associated with the long-term use of PPIs.


Q: Can a person take Lanton if they are pregnant or planning to be?

A: The official FDA label includes a risk summary stating that available data from observational studies suggest Lanton is unlikely to be associated with adverse events in pregnant women. The guidance notes that Lanton should only be considered for use during pregnancy when a clear medical need is established.


Q: Where can I find the official prescribing information for Lanton?

A: The official prescribing information, also known as the Full Prescribing Information or Package Insert, is publicly available. It can be accessed on government websites maintained by regulatory bodies, such as the FDA’s accessdata.fda.gov and the DailyMed portal.


Q: Is Lanton available in a generic version?

A: Regulatory records confirm that a generic formulation of Lansoprazole, the active ingredient in Lanton, is approved and available.


Q: How often is Lanton typically prescribed?

A: According to official product guidelines, Lanton is generally prescribed to be taken once daily for the most common acid-related conditions. However, some specific uses, such as when it is used to eradicate H. pylori bacteria, may require it to be taken more frequently in divided doses.


Q: Does Lanton need to be taken with food?

A: Regulatory drug information specifies that Lanton should be taken before eating a meal, such as 30 minutes before breakfast. It is not generally directed to be taken with food or immediately after a meal.


Q: Is there a maximum amount of Lanton someone can take?

A: The daily dosage for common acid-related conditions is generally 30 mg or less. Official regulatory information also documents that significantly higher doses, up to 180 mg per day in divided doses, may be required for rare, specific conditions that cause extreme acid secretion, such as Zollinger-Ellison Syndrome.


Q: Are there common reasons why a person might stop using Lanton?

A: Regulatory drug information shows that most uses for Lanton are short-term, such as 4 to 12 weeks. This suggests that treatment completion for the underlying acid-related condition is a primary reason for discontinuation.


Q: Can Lanton make you feel tired or drowsy?

A: Official regulatory adverse event data lists fatigue/tiredness and drowsiness as reported side effects.


Q: Do the side effects of Lanton usually go away over time?

A: Patient information from some regulatory bodies notes that certain common side effects, such as headaches, have been observed to lessen or resolve after the initial week of using the medicine.


Q: Is Lanton associated with any mood changes?

A: Rare side effects documented in the official regulatory labeling include anxiety, nervousness, and depression.


Q: Can Lanton cause allergic reactions?

A: Official warnings state that Lanton is contraindicated (should not be taken) in patients who have a known history of an allergic reaction or hypersensitivity to any Proton Pump Inhibitor. Signs of a serious allergic reaction can include hives or swelling of the face and throat.


Q: Does Lanton have a Black Box Warning?

A: The official FDA label for Lanton does not include a Black Box Warning, which is the strictest type of warning required by the FDA. However, a Medication Guide is required to be dispensed due to certain safety risks noted by the FDA.


Q: Are there any known long-term complications of taking Lanton?

A: Official safety communications report possible increased risks of long-term complications associated with continuous use. These include bone fractures (hip, wrist, spine), low blood magnesium, and Vitamin B12 deficiency.


Q: Why is Lanton sometimes used for condition X?

A: Lanton is formally indicated in regulatory documents for conditions like duodenal ulcers, erosive esophagitis, and GERD because its mechanism is to irreversibly reduce the amount of acid the stomach produces.


Q: Does Lanton expire?

A: Yes, like all approved medications, Lanton has an expiration date printed on its packaging. This date ensures that the active ingredient remains stable and potent as intended by the manufacturer.


Q: What is the recommended storage temperature for Lanton?

A: Official product information specifies that Lanton should generally be stored at a controlled room temperature, typically between 20 C to 25 C (68 F to 77 F). It must be protected from moisture and heat.


Q: Is Lanton available over the counter?

A: Lanton is available in a variety of strengths, including both prescription-only forms and a lower-dose, over-the-counter (OTC) formulation that is approved for adults with frequent heartburn.


Q: Are there any restrictions on activity while taking Lanton?

A: Official regulatory guidance states that if Lanton causes symptoms such as dizziness or feeling tired, caution should be exercised regarding activities that require high attention, such as driving or operating heavy machinery.


Q: What kind of studies supported the approval of Lanton?

A: Official regulatory information refers to multiple controlled clinical studies that supported the approval of Lanton for specific uses. These studies confirmed its effectiveness in reducing acid and healing ulcers and erosions associated with conditions like GERD.


Q: Can Lanton affect blood pressure?

A: Official adverse event data mentions rare reports of a fast, pounding, or irregular heartbeat or pulse. While Lanton is not commonly highlighted as directly affecting blood pressure, these cardiovascular symptoms are noted in regulatory documents.

How should Lanton be stored and disposed of?

Storage and Disposal Requirements

Item Regulatory Statement
Storage Temperature Store at controlled room temperature, 20°C to 25°C (68°F to 77°F). Temperature excursions are limited to 15°C to 30°C.
Protection Must be protected from moisture and do not freeze the medication.
Container Rules Store in the original container, which must be kept tightly closed to maintain product stability.
Child Safety Keep the medication out of the sight and reach of children and store in a child-resistant container.
Disposal Instructions Unused or expired Lanton should be discarded using a medicine take-back program. If one is unavailable, mix the medicine with an unappealing substance (like dirt or litter), seal it in a bag, and throw it in the household trash. Do not flush down the toilet.

These official conditions ensure the stability of the delayed-release formulation. The regulatory profile dictates that the medicine must be stored at a defined room temperature, shielded from moisture, and kept sealed in its original container. All disposal must follow proper protocol to prevent accidental exposure and environmental harm.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lanton found in:

A-Z Index: